idazoxan has been researched along with cr4056 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Abás, S; Bagán, A; Brea, J; Brocos-Mosquera, I; Callado, LF; Daelemans, D; de Jonghe, S; Djikic, T; Escolano, C; García-Fuster, MJ; García-Sevilla, JA; Griñán-Ferré, C; Hernández-Hernández, E; Loza, MI; Luque, FJ; Molins, E; Muguruza, C; Naesens, L; Nikolic, K; Pallàs, M; Pérez, B; Pérez-Lozano, P; Radan, M; Rodríguez-Arévalo, S; Vasilopoulou, F | 1 |
Caselli, G; Ferrari, F; Lanza, M; Menghetti, I; Tremolada, D | 1 |
Li, JX; Seaman, RW; Shang, L; Siemian, JN; Zhang, Y; Zhu, Q | 1 |
3 other study(ies) available for idazoxan and cr4056
Article | Year |
---|---|
Bicyclic α-Iminophosphonates as High Affinity Imidazoline I
Topics: Alzheimer Disease; Animals; Chlorocebus aethiops; Cycloaddition Reaction; Dogs; Female; HeLa Cells; Hippocampus; Humans; Imidazoles; Imidazoline Receptors; Ligands; Madin Darby Canine Kidney Cells; Mice; Molecular Structure; Nootropic Agents; Organophosphonates; Quantitative Structure-Activity Relationship; Vero Cells | 2020 |
Modulation of imidazoline I2 binding sites by CR4056 relieves postoperative hyperalgesia in male and female rats.
Topics: Adrenergic alpha-2 Receptor Antagonists; Analgesics; Analgesics, Opioid; Animals; Benzofurans; Binding Sites; Drug Synergism; Female; Hyperalgesia; Idazoxan; Imidazoles; Imidazoline Receptors; Male; Morphine; Naloxone; Narcotic Antagonists; Pain, Postoperative; Quinazolines; Rats, Sprague-Dawley; Yohimbine | 2014 |
Effects of imidazoline I2 receptor agonists on reserpine-induced hyperalgesia and depressive-like behavior in rats.
Topics: Analgesics; Animals; Benzofurans; Depression; Disease Models, Animal; Fibromyalgia; Hyperalgesia; Idazoxan; Imidazoles; Imidazoline Receptors; Imidazolines; Male; Pain; Pain Measurement; Quinazolines; Rats; Rats, Sprague-Dawley; Reserpine | 2019 |